Skip to main content
VCbacked
Log inGet Started

Micron Biomedical

Atlanta, United States

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

$16.0M raised
Jan 2025
Series A
BiopharmaBiotechnologyHealth CareWellness

Top Investors

Bill & Melinda Gates FoundationJ2 VenturesLTS Lohmann Therapie-Systeme AGGlobal Health Investment CorporationGRA Venture Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Micron Biomedical

How much funding has Micron Biomedical raised?
Micron Biomedical has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Who are Micron Biomedical's investors?
Micron Biomedical's investors include Bill & Melinda Gates Foundation, J2 Ventures, LTS Lohmann Therapie-Systeme AG, Global Health Investment Corporation, GRA Venture Fund.
Where is Micron Biomedical headquartered?
Micron Biomedical is headquartered in Atlanta, United States.
What does Micron Biomedical do?
Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.
What stage is Micron Biomedical at?
Micron Biomedical is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Micron Biomedical — Funding & Investors." VCBacked, January 16, 2025, https://www.vcbacked.co/company/micron-biomedical. Accessed June 17, 2026.
APA
VCBacked. (2025). Micron Biomedical — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/micron-biomedical
Wikipedia (cite web)
{{cite web |title=Micron Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/micron-biomedical |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego